A 2,4-diacetylphloroglucinol (DAPG)-inducible expression plasmid encoding tri-functional selection marker, thymidine kinase, Zeocin resistance protein, and monomeric Umikinoko-Green 1 fluorescent protein.
![]() Drawn by SnapGene® software |
|
| Alternative name | pMT916 |
|---|---|
| Clone info. | A 2,4-diacetylphloroglucinol (DAPG)-inducible expression plasmid encoding tri-functional selection marker, TBG, which is a fusion composed of a thymidine kinase from Herpes simplex virus, Zeocin resistance protein from Streptoalloteichus hindustanus, and monomeric Umikinoko-Green 1 fluorescent protein from Sarcophyton sp. |
| Comment | Zeocin resistance protein has D25A mutation. Sequence primers for insert check from depositor : 4130..4157_gaagcgatgatttttgatctattaacag, 4870..4897_GTTTTGGCTTTTGTTGCTTTGATTCCAC, 5975..5950_ATATCGTAAGAGAATGGCAATGGAGC |
| Vector backbone | pRS406 (plasmid) |
| Growth conditions | LB+Amp, 37℃ |
| Gene/insert name | Pseudomonas protegens phlO promoter (DAPG response site); Herpes simplex virus thymidine kinase (hsvTK) cDNA; Streptoalloteichus hindustanus bleomycin (Zeocin) resistance gene genomic DNA; Sarcophyton sp. green fluorescent protein (monomeric Umikinoko-Green 1, mUkG1) cDNA. |
| Depositor|Developer | Ishii, Jun | Tominaga, Masahiro | |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
| Ordering forms | Order form [Credit Card Payment MTA, for use for not-for-profit academic purpose [Word Please visit Information of Request for Distribution.[link] |
|---|---|
| Terms and conditions for distribution | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. (ominaga, M. et al., Nat. Commun. 15,10653, 2024) Additional terms and conditions: A RECIPIENT who belongs to a non-profit organization may use the BIOLOGICAL RESOURCE for an academic research that is non-commercial. The RECIPIENT who belongs to commercial organization should obtain written approval from the Medical & Biological Laboratories Co., Ltd prior to MTA. Further transfer, provision of services or resale of the Zeocin resistance gene, and the Deposited Materials is prohibited without InvivoGen's prior written consent. In addition, InvivoGen's Limited Use Label License applies to your use of this product. |
| Remarks | Zeocin® is a trademark of InvivoGen registered with the United States Patent and Trademark Office and foreign equivalents. See InvivoGen Limited Use Label License. |
[open/close]| 必要書類 | 提供依頼書 提供同意書 (MTA, 非営利学術目的用)[Word 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
|---|---|
| MTAに書く使用条件 | 利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する(ominaga, M. et al., Nat. Commun. 15,10653, 2024)。 付加的使用条件: 非営利機関での学術研究目的での利用に限る。営利機関の利用者もしくは商業利用の場合はMBL社から事前にその旨の提供承諾を取得する。 InvivoGen社の事前の書面による同意がない限り、ゼオシン耐性遺伝子および寄託マテリアルの第三者への移転、サービスの提供、または再販売は禁止されています。また、ご利用に際してInvivoGen社のLimited Use Label Licenseが適用されます。 |
| 備考 | ZeocinはInvivoGen社の製品です。Zeocin®は、米国特許商標庁および米国外の同等機関に登録されたInvivoGen社の商標です。InvivoGen Limited Use Label Licenseをご確認ください。 |
| Catalog # | Resource name | Shipping form | Fee |
|---|---|---|---|
| RDB21033 | pRS406redm-pphlO6-TBG | DNA solution |
Materials & Methods section:
| The pRS406redm-pphlO6-TBG was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB21033). |
Reference section:
| Tominaga, M., Shima, Y., Nozaki, K., Ito, Y., Someda, M., Shoya, Y., Hashii, N., Obata, C., Matsumoto-Kitano, M., Suematsu, K., Matsukawa, T., Hosoya, K., Hashiba, N., Kondo, A., Ishii, J., Designing strong inducible synthetic promoters in yeasts. Nat. Commun. 15 (1): 10653 (2024). PMID 39702268. [PubMed] [Article] [RRC of NBRP] |
Further references such as user reports and related articles (go to bottom)
Original, user report and related articles
| original | Tominaga, M., Designing strong inducible synthetic promoters in yeasts. Nat. Commun. 15 (1): 10653 (2024). PMID 39702268. [PubMed] [Article] [RRC of NBRP] |
|---|
Featured content